Medical Devices
Medical Device Entry Requires Institutional Patience
A practical view on why medical device companies need careful stakeholder sequencing when entering the Nigerian healthcare market.
Medical device decisions move through institutions
Medical devices are rarely adopted because one person is interested. Decisions may involve clinical champions, biomedical engineering teams, procurement leaders, finance stakeholders, hospital executives, and sometimes external investors or public-sector partners.
This makes sequencing important. The right conversation at the wrong time can still fail.
Local representation protects credibility
International manufacturers need a trusted local partner who understands how to present the company, qualify opportunity, and avoid premature commercial pressure. That partner must represent the manufacturer clearly without creating distributor confusion.
REVAYAH supports this by helping device companies build strategic healthcare relationships and develop commercial pathways over time.
The goal is repeatable market presence
Strong entry work should not only produce a first opportunity. It should help establish the relationships, market intelligence, and commercial habits required for long-term growth.